New York-based Clayton, Dubilier & Rice has exited its interest in BCA to Haversham Holdings. The transaction is valued at approximately £1.2 billion.
Shareholders of BCA, which include CD&R funds, will receive £701 million in cash and £104 million in stock.
Clayton, Dubilier & Rice declined to comment on the transaction.
The deal is expected to close in early April, and sources familiar with the matter place the exit at a 3x return for CD&R.
BCA is Europe’s largest used vehicle network, and was first acquired by CD&R from Montagu Private Equity in 2009. That transaction was valued at approximately £400m. BCA has since expanded its network to include operations in Brazil.
CD&R has seen a few notable exits recently including Envision Healthcare which returned above 5x, and B&M Retail which held its IPO in June 2014.
CD&R is currently investing out of its $6.4 billion Fund IX, which closed in May according to Private Equity International’s research and analytics division. Last May, CD&R acquired Healogics, the largest advanced wound care services provider in the US, from Metalmark Capital and Scale Venture Partners for $910 million. In December 2013, the firm also invested in PharMEDium, a national provider of hospital pharmacy-outsourced sterile compounding services.
Earlier this month, the firm appointed Ravi Sachdev, a former managing director and co-head of healthcare services at J.P. Morgan to partner to work on healthcare investments, PEI reported at the time.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: